---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-080728"
form_type: "8-K"
ticker: "BHC"
cik: "0000885590"
company_name: "Bausch Health Companies Inc."
filed_at: "2025-04-15T23:59:59+00:00"
generated_at: "2026-05-23T15:15:29.121276+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Bausch Health adopts shareholder rights plan (poison pill) effective April 14, 2025

## Summary
- Board approved shareholder rights plan on April 14, 2025; one right attaches to each common share outstanding.
- Plan not adopted in response to any specific takeover bid or proposal; Board is unaware of any pending threat.
- Rights become exercisable at a substantial discount if a person acquires 20%+ of common shares (subject to Permitted Bid exception).
- Plan subject to TSX acceptance and shareholder ratification within six months; if not ratified, it terminates.
- Similar to other Canadian public company shareholder rights plans.

## SEC filing metadata
- accession: 0001193125-25-080728
- form_type: 8-K
- ticker: BHC
- cik: 0000885590
- company_name: Bausch Health Companies Inc.
- filed_at: 2025-04-15T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 3.03, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/885590/000119312525080728/0001193125-25-080728-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/885590/000119312525080728/d923035d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-080728
- JSON: https://secwatch.observer/filing/0001193125-25-080728.json
- Plain text: https://secwatch.observer/filing/0001193125-25-080728.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.